Publication | Open Access
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study
94
Citations
23
References
2020
Year
Therapy with dupilumab led to a significant improvement of AD over a 16-week treatment period, with a good safety profile. Therefore, dupilumab could be considered as an efficacious and safe treatment for AD also in the elderly.
| Year | Citations | |
|---|---|---|
Page 1
Page 1